HEATHER PODESTA appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Source-backed chronology
Dates not reported
Federal government
Inspect source ↗Dates not reported
Documented career transitions
Congress → Lobbying
Federal governmentCounsel, Representative Robert Matsui (2003); Counsel, Representative Earl Pomeroy (2002-2003); Legislative Fellow, Senator Bill Bradley (1993-1994); Research Assistant, Congressional Budget Office (1992)↓Palantir TechnologiesRegistered lobbyistFederal LDA filings
Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.
LDA filing ↗Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.
LDA filing ↗Registrant: INVARIANT LLC · Health Issues
Education regarding Palantir commercial software, including efforts for the COVID-19 response; highlight commercial benefits of software solutions.
LDA filing ↗Registrant: INVARIANT LLC · Health Issues
Discuss the federal governments use of Palantirs commercial software including efforts for the COVID-19 response; highlight commercial benefits of software solutions; highlight projects within HHS, NIH, and FDA; support federal funding for maintaining systems put in place for the COVID-19 response.
LDA filing ↗Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; encourage support for maintaining systems put in place for COVID-19 to address future public health emergencies.
LDA filing ↗Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; and support funding for the Food and Drug Administrations 21Forward initiative.
LDA filing ↗Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantirs commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; support funding for the Food and Drug Administrations 21Forward initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act.
LDA filing ↗Registrant: INVARIANT LLC · Health Issues
Discuss the use of Palantir's commercial software to assist the COVID-19 response; highlight benefits of a commercial software solution; support data sharing models at the National Institutes of Health; support funding for the Food and Drug Administration's 21Forward initiative; monitor Senate pandemic preparedness legislation including S.3799, PREVENT Pandemics Act.
LDA filing ↗